These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20798226)

  • 1. Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.
    Hofsø D; Nordstrand N; Johnson LK; Karlsen TI; Hager H; Jenssen T; Bollerslev J; Godang K; Sandbu R; Røislien J; Hjelmesaeth J
    Eur J Endocrinol; 2010 Nov; 163(5):735-45. PubMed ID: 20798226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents.
    Inge TH; Miyano G; Bean J; Helmrath M; Courcoulas A; Harmon CM; Chen MK; Wilson K; Daniels SR; Garcia VF; Brandt ML; Dolan LM
    Pediatrics; 2009 Jan; 123(1):214-22. PubMed ID: 19117885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.
    Ikramuddin S; Korner J; Lee WJ; Connett JE; Inabnet WB; Billington CJ; Thomas AJ; Leslie DB; Chong K; Jeffery RW; Ahmed L; Vella A; Chuang LM; Bessler M; Sarr MG; Swain JM; Laqua P; Jensen MD; Bantle JP
    JAMA; 2013 Jun; 309(21):2240-9. PubMed ID: 23736733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial.
    Ikramuddin S; Korner J; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Wang Q; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Olofson AE; Bainbridge HA; Billington CJ
    Diabetes Care; 2016 Sep; 39(9):1510-8. PubMed ID: 27311493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention.
    Hofsø D; Jenssen T; Bollerslev J; Ueland T; Godang K; Stumvoll M; Sandbu R; Røislien J; Hjelmesæth J
    Eur J Endocrinol; 2011 Feb; 164(2):231-8. PubMed ID: 21078684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial.
    Courcoulas AP; Belle SH; Neiberg RH; Pierson SK; Eagleton JK; Kalarchian MA; DeLany JP; Lang W; Jakicic JM
    JAMA Surg; 2015 Oct; 150(10):931-40. PubMed ID: 26132586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.
    Simonson DC; Halperin F; Foster K; Vernon A; Goldfine AB
    Diabetes Care; 2018 Apr; 41(4):670-679. PubMed ID: 29432125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial.
    Ikramuddin S; Billington CJ; Lee WJ; Bantle JP; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Wang Q; Korner J
    Lancet Diabetes Endocrinol; 2015 Jun; 3(6):413-422. PubMed ID: 25979364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.
    Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F
    Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.
    Halperin F; Ding SA; Simonson DC; Panosian J; Goebel-Fabbri A; Wewalka M; Hamdy O; Abrahamson M; Clancy K; Foster K; Lautz D; Vernon A; Goldfine AB
    JAMA Surg; 2014 Jul; 149(7):716-26. PubMed ID: 24899464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary function and blood gases after gastric bypass and lifestyle intervention: a comparative study.
    Gabrielsen AM; Lund MB; Kongerud J; Viken KE; Røislien J; Hjelmesaeth J; Hofsø D
    Clin Obes; 2013 Oct; 3(5):117-23. PubMed ID: 25586626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
    Schiavon CA; Bersch-Ferreira AC; Santucci EV; Oliveira JD; Torreglosa CR; Bueno PT; Frayha JC; Santos RN; Damiani LP; Noujaim PM; Halpern H; Monteiro FLJ; Cohen RV; Uchoa CH; de Souza MG; Amodeo C; Bortolotto L; Ikeoka D; Drager LF; Cavalcanti AB; Berwanger O
    Circulation; 2018 Mar; 137(11):1132-1142. PubMed ID: 29133606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Differences in Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery-Subgroup Analysis of 2-Year Results of the Diabetes Surgery Study Comparing Taiwanese with Americans with Mild Obesity (BMI 30-35 kg/m
    Chong K; Ikramuddin S; Lee WJ; Billington CJ; Bantle JP; Wang Q; Thomas AJ; Connett JE; Leslie DB; Inabnet WB; Jeffery RW; Sarr MG; Jensen MD; Vella A; Ahmed L; Belani K; Schone JL; Olofson AE; Bainbridge HA; Laqua PS; Korner J; Chuang LM
    Obes Surg; 2017 May; 27(5):1189-1195. PubMed ID: 27783367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity: The SLEEVEPASS Randomized Clinical Trial.
    Salminen P; Helmiö M; Ovaska J; Juuti A; Leivonen M; Peromaa-Haavisto P; Hurme S; Soinio M; Nuutila P; Victorzon M
    JAMA; 2018 Jan; 319(3):241-254. PubMed ID: 29340676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(1):1-148. PubMed ID: 23074460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical Activity in Obese Type 2 Diabetes After Gastric Bypass or Medical Management.
    Panosian J; Ding SA; Wewalka M; Simonson DC; Goebel-Fabbri A; Foster K; Halperin F; Vernon A; Goldfine AB
    Am J Med; 2017 Jan; 130(1):83-92. PubMed ID: 27555097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roux-en-Y gastric bypass decreases serum inflammatory markers and cardiovascular risk factors in obese diabetics.
    Rossi I; Omotosho P; Poirier J; Spagnoli A; Torquati A
    Surgery; 2021 Mar; 169(3):539-542. PubMed ID: 33168209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study.
    Olbers T; Beamish AJ; Gronowitz E; Flodmark CE; Dahlgren J; Bruze G; Ekbom K; Friberg P; Göthberg G; Järvholm K; Karlsson J; Mårild S; Neovius M; Peltonen M; Marcus C
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):174-183. PubMed ID: 28065734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Cardiovascular Risk after Roux-en-Y Gastric Bypass Surgery in Chinese Diabetic Patients with Obesity.
    Zhao X; Duan W; Sun C; Li Z; Liu Y; Xiao X; Wang G; Gang X; Wang G
    J Diabetes Res; 2017; 2017():5612049. PubMed ID: 28744472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study.
    Ikramuddin S; Korner J; Lee WJ; Thomas AJ; Connett JE; Bantle JP; Leslie DB; Wang Q; Inabnet WB; Jeffery RW; Chong K; Chuang LM; Jensen MD; Vella A; Ahmed L; Belani K; Billington CJ
    JAMA; 2018 Jan; 319(3):266-278. PubMed ID: 29340678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.